Very large Atrial Septal Defect Device Closure: Feasibility and safety
Abstract
Objectives: There is limited data regarding feasibility and safety of very large ASD devices deployment. Percutaneous closure of very large atrial septal defect (ASD) is a valid alternative to surgical approach. But complications like erosion, cardiac perforation, atrioventricular block, pericardial effusion, infective endocarditis, or cardiac arrhythmias may occur following ASD device closure.
Methods: Forty four patients with very large ostium secundum ASD were studied in a tertiary medical centre. Adult patients with defect size of 38 mm or more and device size of 40 mm or more were selected for device closure. Patients having suitable anatomy, significant left to right shunt(>1.5:1) ,right ventricular volume overload and without significant pulmonary arterial hypertension were chosen for device closure.
Results : There were thirty six female patients and eight male patients in our study. Majority of our patients (twenty four) were in forty to fifty years age group. Device could be deployed successfully in forty two (95.5%). Twelve patients had device size of 46 mm (27%). Eight patients had 44 mm devices(18%). Forty two millimeter devices were used in sixteen patients (36%). Eight patients had device size of 40 mm(18%).Device embolization occurred in two patients. There were two cases of pericardial effusion and pericardiocentesis was needed in one patients. Transient complete heart block was seen in one patient. Four patients had suffered from transient and self terminating atrial arrhythmias. There was no mortality or erosion in our study.
Conclusion: Percutaneous closure of very large ASD is feasible and associated with low complication rate
Downloads
References
2)Ooi YK, Kelleman M, Ehrlich A,Glanville M,Porter A,Kim D et al. Transcatheter versus surgical closure of atrial septal defects in children: a value comparison. JACC Cardiovascular Intervention. 2016; 9:79–86.
3)Fraisse A, Trivedi K. R. Transcatheter closure of atrial septal defects: how large is too large? Cardiovascular Diagnosis and Therapy.2014 Jun; 4(3): 213–214.
4) Butera G, Romagnoli E, Carminati M, Piazza L, Negura D, Giamberti A
et al. Treatment of isolated secundum atrial septal defects: impact of age and defect morphology in 1,013 consecutive patients. Americal Heart Journal. 2008;156:706-12
5)A.E. Baruteau A.E, Petit J, Lambert V,Gouton M,Piot D,Brenot Pet al. Transcatheter closure of large atrial septal defects: feasibility and safety in a large adult and pediatric population. Circulation Cardiovascular Intervention. 2014;7: 837-843.
4)J.I. Hoffman, S. Kaplan. The incidence of congenital heart disease
Journal of American College of Cardiology.2002;39:1890-1900.
5)Podnar T, Martanovic P, Gavora P ,Masura J.Morphological variations of secundum-type atrial septal defects: feasibility for percutaneous closure using Amplatzer septal occluders. Catheter Cardiovascular Intervention. 2001; 53:386–391.
6)Martin G.R,Beekman R.H, Ing F.F,Jenkin K.J,Mc Kay CR,Moore JW et al. The IMPACT registry: IMproving Pediatric and Adult Congenital Treatments. Seminars in Thoracic and Cardiovascular Surgery, Pediatric Cardiac Surgery Annual. 2010;13:20-25.
7)D.S. Levi, J.W. Moore. Embolization and retrieval of the Amplatzer septal occlude. Catheter Cardiovascular Intervention.2004 ;61:543-547.
8)M. Chessa, M. Carminati, G. Butera et al. Early and late complications associated with transcatheter occlusion of secundum atrial septal defect
Journal of American College of Cardiology.2002;39:1061-1065.
9)Alessia Faccini and Gianfranco Butera. Atrial septal defect (ASD) device trans-catheter closure: limitations. Journal of Thoracic Diseases. 2018 ;Sep; 10(Suppl 24): 2923–2930.
10) S.J. Al-Anani, H. Weber, Z.M. Hijazi. Atrioventricular block after transcatheter ASD closure using the Amplatzer septal occluder: risk factors and recommendations. Catheter Cardiovascular Intervention. 2010 ;75:767-772.
11) Auriau J,Bouvaist H, Aaberge L,Abe T, Dahnert I,Panjer J et al. Cardiac Erosions After Transcatheter Atrial Septal Defect Closure With the Occlutech Figulla Flex Device. JACC: Cardiovascular Interventions.2019;12(14):1397-1399.
12) DiBardino D.J, Mc Elhinney D.B, Kaza A.K, Mayer JE . Analysis of the U.S. Food and Drug Administration Manufacturer and User Facility Device Experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery congenital cardiac surgery database. Journal of Thoracic Cardiovascular Surgery.2009;137:1334-1341
13)J.N. Johnson, M.L. Marquardt, M.J. Ackerman et al. Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure. Catheter Cardiovascular Intervention. 2011;78:254-261.
14) Lopez K, Dalvi BV, Balzer D, John L Bass J.L, Momenah T, Cao Q.L et al. Transcatheter closure of large secundum atrial septal defects using the 40 mm Amplatzer septal occluder: results of an international registry. Catheter Cardiovascular Intervention. 2005;66:580-4
15) Thanopoulos BD, Dardas P, Ninios V, Nicholaos Eleftherakis N, Evangelos Karanasios E.Transcatheter closure of large atrial septal defects with deficient aortic or posterior rims using the “Greek maneuver”. A multicenter study. International Journal of Cardiology. 2013;168:3643-6
PDF downloads: 1214
Copyright (c) 2021 Indonesian Journal of Cardiology
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
